Viseon Spine closed a Series-A financing round.
Here are five highlights:
1. The company received $5 million in the round, led by HBM-MedFocus, Invus Opportunities Fund and Wexford Capital LP affiliates.
2. Viseon Spine plans to put the funding toward product development, global regulatory approvals, clinical evaluations as well as manufacturing scale-up and commercialization.
3. The company develops minimally invasive spine surgery access devices that are single use and disposable.
4. Surgeons may use the Viseon technologies for posterior cervical, thoracic and lumbar procedures as well as advanced lateral access procedures.
5. The technologies are intended to cut capital equipment cost; operating room footprint and scheduling; maintenance and calibration expense; sterilization issues; and procedural inefficiencies.